AI assistant
Sending…
Cytosorbents Corp — Director's Dealing 2012
Jan 23, 2012
34501_dirs_2012-01-23_05b7fa92-2497-477c-9d25-2d913fefba63.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2012-01-18
Reporting Person: Kraus Al (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-01-18 | Stock Option | $0.164 | A | 100000 | Acquired | 2022-01-18 | Common Stock (100000) | Direct |
Footnotes
F1: As compensation for services rendered, in 2011, on January 18, 2012 Mr. Al Kraus was issued an option to purchase 100,000 shares of common stock at an exercise price of $0.164 per share which will expire on January 18, 2022.
More from Cytosorbents Corp
Annual Report
2026
Apr 15
Delisting Announcement
2026
Apr 2
Annual Report
2026
Mar 30
Earnings Release
2026
Mar 25
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2025
Nov 21
Earnings Release
2025
Nov 13
Interim / Quarterly Report
2025
Nov 13
Delisting Announcement
2025
Oct 3
Regulatory Filings
2025
Sep 16